NSEShareholders meeting2d ago · 18 Aug 2026, 03:51 pm

Shareholders meeting

Mankind Pharma Limited · MANKIND

✦ AI SummaryMgmt Change

Mankind Pharma Limited has informed the Exchange regarding Notice of Postal Ballot for appointment of Mr. Anish Vanraj Bafna as a Non-Executive Independent Director of the Company.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mankind Pharma Limited has informed the Exchange regarding Notice of Postal Ballot

Attachments (1)

📄

MANKIND1_18082026155056_CoverPB.pdf

pdf

Download →
View document text
August 18, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Postal Ballot Notice Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to the captioned subject, please find enclosed herewith the Postal Ballot Notice (“Notice”) dated August 10, 2026, for seeking approval of the Members by way of Special Resolution through postal ballot via remote e-voting (“e-voting”) for appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as a Non-Executive Independent Director of the Company. In accordance with the applicable provisions of General Circular No. 14/2020 dated April 8, 2020 and General Circular No. 17/2020 dated April 13, 2020, read with other relevant circulars, including General Circular No. 03/2025 dated September 22, 2025, issued by the Ministry of Corporate Affairs, and the various circulars issued by the Securities and Exchange Board of India in this regard, the aforesaid Notice has been dispatched electronically on Tuesday, August 18, 2026, to the Members whose names appear in the Register of Members of the Company and/or in the Register of Beneficial Owners maintained by the Depositories as on Friday, August 14, 2026 (“Cut-off Date”) and whose e-mail addresses are registered with the Company/Depositories. The communication of assent or dissent by the Members in respect of the Special Resolution proposed in the Notice shall take place only through the remote e-voting system. The Company has appointed National Securities Depository Limited (“NSDL”) for facilitating e-voting to enable the members to cast their votes electronically. Details pertaining to e-voting are as follows: Cut-off Date Friday, August 14, 2026 Commencement of e-voting period Wednesday, August 19, 2026 (9:00 AM IST) End of e-voting period Thursday, September 17, 2026 (5:00 PM IST) (both days inclusive) Declaration of results of e-voting On or before Monday, September 21, 2026 Please note that, the Notice is also available at the website of the Company i.e. www.mankindpharma.com and at the website of website of NSDL at www.evoting.nsdl.com. Further, upon declaration, the voting results along with the Scrutinizer’s Report shall be uploaded on the website of the Company at www.mankindpharma.com and on the website of NSDL at www.evoting.nsdl.com, and shall also be communicated to and uploaded on the websites of BSE Limited at www.bseindia.com and National Stock Exchange of India Limited at www.nseindia.com. This is for your information and necessary dissemination. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a MANKIND PHARMA LIMITED Registered Office: 208, Okhla Industrial Estate, Phase III, New Delhi 110020, Delhi, India. Telephone No. +91 11 47476600 Corporate Office: 262, Okhla Industrial Estate, Phase III, New Delhi 110020, Delhi, India. Telephone No. +91 11 46846700 CIN: L74899DL1991PLC044843 Website: www.mankindpharma.com | Email: investors@mankindpharma.com NOTICE OF POSTAL BALLOT S. No. Index Section Page No. 1. Notice of Postal Ballot/E-voting 01 2. Notes to the Notice & E-voting Procedure 02-06 3. Explanatory Statement 07-08 4. Brief Profile 09 PROPOSAL S. No. Proposed Resolution Type of Resolution 1. Appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as a Non- Special Resolution Executive Independent Director Postal Ballot / E-voting Timeline: Cut-off Date for Voting Opens Voting Closes Result E-voting Friday, August Wednesday, August 19, 2026 Thursday, September 17, 2026 On or before Monday, 14, 2026 (9:00 AM IST) (5:00 PM IST) (both days inclusive) September 21, 2026 The Notice of the Postal Ballot/E-voting and Explanatory Statement is prepared pursuant to the applicable provisions of the Companies Act, 2013 (“Act”) and Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), as amended from time to time. Back to Index 01-09 NOTICE OF POSTAL BALLOT [Pursuant to Section 110 and Section 108 of the Companies Act, 2013, read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014] Dear Member(s), designated as a Non-Executive Independent Director of the Company with effect from August 10, 2026, Notice is hereby given that the resolution set out below pursuant to the provisions of Section 161 of the Act is proposed for approval by the members of Mankind read with Articles of Association of the Company and Pharma Limited (“the Company”) by means of Postal based upon the recommendation of the Nomination Ballot, only by remote e-voting process (“e-voting”) and Remuneration Committee and who has consented being provided by the Company to all its members to to act as a Director of the Company and who meets the cast their votes electronically, pursuant to Section 110 criteria for independence as provided under Section of the Act, Rule 22 of the Companies (Management 149(6) of the Act and Regulation 16(1)(b) of the Listing and Administration) Rules, 2014 (“the Rules”) and Regulations, and has submitted a declaration to that other applicable provisions of the Act and the Rules, effect, be and is hereby appointed as a Non-Executive General Circular Nos. 14/2020 dated April 8, 2020 and Independent Director of the Company, not liable to retire 17/2020 dated April 13, 2020 read with other relevant by rotation, for a term of five (5) consecutive years circulars, including General Circular No. 03/2025 commencing from August 10, 2026. dated September 22, 2025, issued by the Ministry of Corporate Affairs (“MCA Circulars”), Regulation 44 of RESOLVED FURTHER THAT Mr. Anish Vanraj Bafna the Listing Regulations, Secretarial Standard on General shall be entitled to receive the sitting fees for attending Meetings (“SS-2”) issued by the Institute of Company meetings of the Board or its Committees, or such other Secretaries of India and other applicable laws, rules and meetings, at a rate, as may be decided by the Board regulations (including any statutory modification(s) or from time to time, reimbursement of expenses incurred re-enactment(s) thereof for the time being in force). for participating in the Board and other meetings and profit-related commission as may be decided by the The Statement, pursuant to the provisions of Section Board from time to time, subject to the limits and 102(1) and other applicable provisions of the Act read provisions prescribed under Sections 197, 198 and any with the Rules, setting out all material facts relating to other applicable provisions of the Act and the rules the resolution proposed in this Postal Ballot Notice and made thereunder and applicable provisions of the additional information as required under the Listing Listing Regulations, each as may be amended from Regulations and circulars issued thereunder is attached. time to time. RESOLVED FURTHER THAT the Board of Directors of SPECIAL BUSINESS: the Company or any person(s) authorised by the Board be and is hereby authorised to do all such acts, deeds, Item No. 1: Appointment of Mr. Anish Vanraj Bafna matters and things, and to execute all such documents, (DIN: 02925792) as a Non-Executive Independent writings and instruments, as may be necessary, Director expedient or desirable for the purpose of giving effect To consider and, if thought fit, to pass the following to this resolution and to settle any question, difficulty or resolution as a Special Resolution: doubt that may arise in this regard.” “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions, By Order of the Board of Directors if any, read with Schedule IV of the Companies Act, For Mankind Pharma Lim [Showing first 8,000 characters — download PDF for full document]